From: Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity in vitro
Antiproliferation activity (IC50: μM)
Kinase inhibition (Kd50μM)
PC-3
Du145
MRCKα
2.226 ± 0.28
1.67 ± 0.18
0.26